The chemotherapy of human and animal acute leukemia.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001377:Azaserine / Q000627:therapeutic use; D002455:Cell Division; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004338:Drug Combinations; D006801:Humans; D007700:Kinetics; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms; D011241:Prednisone / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004338:Drug Combinations; D012334:RNA, Neoplasm; D003561:Cytarabine; D014750:Vincristine; D001377:Azaserine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate